Skip to main content

Khosla Ventures SPAC cancels $2.8B Valo Health merger a day before shareholder vote

Khosla and Boston-based Valo Health gave “current market conditions, particularly in the biotechnology area,” as the reason for calling off the deal, which was announced in June.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.